Thomas Rosenbloom

Thomas Rosenbloom serves as President & Chief Legal Officer at FreMon Scientific. He also serves as Director & Board Member at FreMon Scientific. Rosenbloom serves as Secretary, Executive Vice President, Business Development & General Counsel at CYS Investments. He is our Executive Vice President of Business Development, General Counsel and Secretary. Rosenbloom has served as our Secretary since June 2007. From May 2007 through August 2011, Rosenbloom served as General Counsel and Secretary to Sharpridge. Prior to joining Sharpridge in May 2007, from February 2005 through May 2007, Rosenbloom was a partner with Foley & Lardner, LLP and a member of the firm's Private Equity & Venture Capital and Transactional & Securities Practices. Rosenbloom was also a member of the firm's Emerging Technologies, Life Sciences and Nanotechnology Industry Tea From 1998 through January 2005, Rosenbloom was a partner with Epstein, Becker & Green, P.C. During Rosenbloom's tenure at Foley & Lardner and Epstein, Becker & Green, both national law firms, he represented middle-market public companies, entrepreneurs, founders, emerging businesses, start-up corporations and partnerships in diverse industries. Rosenbloom managed and negotiated mergers and acquisitions, private equity and venture capital financings and private placements. While in private practice, Rosenbloom was responsible for developing and managing all aspects of client relationships, including analyzing and evaluating financing, acquisition and divestiture opportunities, writing and developing business plans and providing other planning and financial advice, including with respect to intellectual property protection, labor and employment, immigration and real estate matters. Rosenbloom has a BA in Economics from the University of Wisconsin and a JD from the Boston University School of Law.